Meanwhile, moderate bleeding was more common following cangrelor bridging infusions >0.75 mcg/kg/min (4.4% vs 0% with lower ...
Cerus Corporation (Nasdaq: CERS) announced today the signing of a new, four-year supply agreement with Établissement Français du Sang (EFS), the French Blood Establishment, for the INTERCEPT Blood ...
A multi-center retrospective cohort study examined how cangrelor has been used in real-world clinical practice around the ...
Daratumumab produced rapid and sustained platelet responses in adults with immune thrombocytopenia (ITP), according to a recent single-center, open-label, phase 2 clinical trial (NCT05562882). Despite ...
Filing acceptance based on Phase III ALLEGORY data for Gazyva showing a significant reduction in disease activity compared with placebo in people with systemic lupus erythematosus (SLE)If approved, ...
Filing acceptance based on Phase III ALLEGORY data for Gazyva showing a significant reduction in disease activity compared with placebo in people with systemic lupus erythematosus (SLE)If approved, ...
Autologous blood transfusion (ABT) has been gradually attracting more attention due to the increasingly prominent problem of blood transfusion safety and blood shortage in recent years. With the rapid ...
Myelodysplastic syndromes (MDS) can damage bone marrow, lowering red blood cells and platelets. Transfusions replace missing cells to manage anemia or thrombocytopenia. Up to 9 in 10 people with MDS ...
Objective Despite lack of evidence supporting efficacy, prophylactic fresh frozen plasma and Octaplas transfusions may be administered to very preterm infants to reduce bleeding risk. International ...
For people living with primary immunodeficiency (PI), immunoglobulin replacement therapy is an essential part of preventing serious infections. The treatment can be delivered through an IV ...
Platelet transfusion is a critical intervention for patients at risk of bleeding, particularly in neonatal and paediatric settings. In a large multicentre cohort study analysing 249 340 inpatient ...